Kanjer K - Search Results

1

Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.

Nikolić-Vukosavljević D, Markićević M, Grujić-Adanja G, Petrović A, Kanjer K, Nesković-Konstantinović Z. Nikolić-Vukosavljević D, et al. Among authors: kanjer k. Clin Exp Metastasis. 2005;22(4):363-8. doi: 10.1007/s10585-005-1265-8. Clin Exp Metastasis. 2005. PMID: 16170672

2

Variations in the content of steroid receptors in breast cancer. Comparison between primary tumors and metastatic lesions.

Branković-Magić MV, Nikolić-Vukosavljević DB, Nesković-Konstantinović ZB, Kanjer KS, Spuzić IV. Branković-Magić MV, et al. Among authors: kanjer ks. Acta Oncol. 1992;31(6):629-33. doi: 10.3109/02841869209083844. Acta Oncol. 1992. PMID: 1281649

3

Estrogen and progesterone receptor content in bilateral breast cancer.

Branković-Magić M, Nikolić-Vukosavljević D, Nesković-Konstantinović Z, Kanjer K, Spuzić I. Branković-Magić M, et al. Among authors: kanjer k. Pathol Res Pract. 1995 Feb;191(1):16-24. doi: 10.1016/S0344-0338(11)80917-9. Pathol Res Pract. 1995. PMID: 7651928

4

Association among an autocrine parameter (EGF-R) and endocrine parameters (ER and PR) in locoregional breast cancer.

Nikolić-Vukosavljević D, Kanjer K, Branković-Magić M, Spuzić I. Nikolić-Vukosavljević D, et al. Among authors: kanjer k. Neoplasma. 1994;41(3):137-40. Neoplasma. 1994. PMID: 7935980

5

Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.

Nesković-Konstantinović Z, Nikolić-Vukosavljević D, Branković-Magić M, Kanjer K, Gavrilović D, Mitrović L, Borojević N, Vukotić D, Spuzić I. Nesković-Konstantinović Z, et al. Among authors: kanjer k. J Exp Clin Cancer Res. 1999 Sep;18(3):347-55. J Exp Clin Cancer Res. 1999. PMID: 10606181

6

Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer.

Nikolic-Vukosavljevic D, Kanjer K, Neskovic-Konstantinovic Z, Vukotic D. Nikolic-Vukosavljevic D, et al. Among authors: kanjer k. Int J Biol Markers. 2002 Jul-Sep;17(3):196-200. doi: 10.1177/172460080201700309. Int J Biol Markers. 2002. PMID: 12408471 Free article.

7

Natural course of node-negative breast cancer: high risk-related subgroups.

Nikolić-Vukosavljević D, Kanjer K, Markicević M, Todorović-Raković N, Vukotić D, Nesković-Konstantinović Z. Nikolić-Vukosavljević D, et al. Among authors: kanjer k. J Exp Clin Cancer Res. 2003 Dec;22(4):543-9. J Exp Clin Cancer Res. 2003. PMID: 15053295

8

Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.

Mandusić V, Nikolić-Vukosavljević D, Tanić N, Kanjer K, Neskovic-Konstantinović Z, Celeketić D, Dimitrijević B. Mandusić V, et al. Among authors: kanjer k. J Cancer Res Clin Oncol. 2007 Aug;133(8):571-9. doi: 10.1007/s00432-007-0209-x. Epub 2007 Apr 25. J Cancer Res Clin Oncol. 2007. PMID: 17457609

9

Estrogen-regulated cut-off values of pS2 and cathepsin D expression in breast carcinomas.

Markićević M, Petrović A, Kanjer K, Nesković-Konstantinović Z, Nikolić-Vukosavujević D. Markićević M, et al. Among authors: kanjer k. Adv Exp Med Biol. 2008;617:341-8. doi: 10.1007/978-0-387-69080-3_32. Adv Exp Med Biol. 2008. PMID: 18497057

10

Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer.

Mandusic V, Dimitrijevic B, Nikolic-Vukosavljevic D, Neskovic-Konstantinovic Z, Kanjer K, Hamann U. Mandusic V, et al. Among authors: kanjer k. Cancer Lett. 2012 Aug 1;321(1):73-9. doi: 10.1016/j.canlet.2012.02.022. Epub 2012 Feb 24. Cancer Lett. 2012. PMID: 22366496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters